Advertisement

Topics

Nuclear Medicine - Biotech, Pharma and Life Science Channel

11:42 EDT 25th March 2017 | BioPortfolio

Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease.

In nuclear medicine procedures, radionuclides are combined with other elements to form chemical compounds, or else combined with existing pharmaceutical compounds, to form radiopharmaceuticals. These radiopharmaceuticals, once administered to the patient, can localize to specific organs or cellular receptors.

This property of radiopharmaceuticals allows nuclear medicine the ability to image the extent of a disease process in the body, based on the cellular function and physiology, rather than relying on physical changes in the tissue anatomy. In some diseases, nuclear medicine studies can identify medical problems at an earlier stage than other diagnostic tests. 

Treatment of diseased tissue, based on metabolism or uptake or binding of a particular ligand, may also be accomplished, similar to other areas of pharmacology. However, the treatment effects of radiopharmaceuticals rely on the tissue-destructive power of short-range ionizing radiation.

In the future, nuclear medicine may provide added impetus to the field known as molecular medicine. As understanding of biological processes in the cells of living organisms expands, specific probes can be developed to allow visualization, characterization, and quantification of biologic processes at the cellular and subcellular levels.[

Source: Wikipedia

 

News Articles [49 Associated News Articles listed on BioPortfolio]

Nuclear Medicine/Radiopharmaceutical Global Market Forecast To 2022 [Updated: 24032016] Prices from USD $4500

Way back to the history, over the past 50 years nuclear medicine sector has displayed a strong link between investments in chemistry and development of radionuclide's and radiolabeled compounds. This ...

Cerveau Technologies, Inc. Executes a Binding Term Sheet with Sinotau Pharmaceutical Group for Novel Investigational Tau Imaging Agent

Cerveau Technologies, Inc. today announced the execution of a binding term sheet with Sinotau Pharmaceutical Group for investigational imaging agent (MK-6240) being evaluated for ...

OncoSil Medical Ltd OSL Medical Equipment Deals and Alliances Profile [Updated: 24012017] Prices from USD $250

SummaryOncoSil Medical Ltd OncoSil, formerly NeuroDiscovery Limited is a biotechnology company that develops and commercializes products for the neurology market. The company offers products such as N...

Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of ...

Cyclopharm Ltd CYC Medical Equipment Deals and Alliances Profile [Updated: 14022017] Prices from USD $250

SummaryCyclopharm LtdCyclopharm is a radiopharmaceutical company which manufactures medical and healthcare equipment and components in the nuclear medicine business. The company's products include Tec...

Advanced Accelerator Applications SA AAAP Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 25012017] Prices from USD $250

SummaryAdvanced Accelerator Applications SA AAA is a radiopharmaceutical company that develops, produces and markets molecular nuclear medicine diagnostic and therapeutic products. The company's lead ...

Advanced Accelerator Applications SA AAAP Medical Equipment Deals and Alliances Profile [Updated: 14022017] Prices from USD $250

SummaryAdvanced Accelerator Applications SA AAA is a radiopharmaceutical company that develops, produces and markets molecular nuclear medicine diagnostic and therapeutic products. The company's lead ...

Synergy Radiology Associates Expands Treatment Options for Patients with Colon Cancer That Has Spread to the Liver

New NCCN cancer treatment guidelines expand use of tumor-targeting Y-90 radiation treatment to patients with liver dominant, chemotherapy resistant colorectal cancer Ra...

Lantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18

Lantheus Medical Imaging, Inc. (“LMI”), a subsidiary of Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), and

International Isotopes Inc. Announces The Successful Private Placement Of Its Preferred Series C Stock

IDAHO FALLS, Idaho, Feb. 21, 2017 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") announces that is has completed a private placement with certain investors for approxim...

Events [0 Results]

None

Companies [9 Associated Companies listed on BioPortfolio]

Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation (ADMD) is a late stage development company engaged in the development of brachytherapy devices for therapeutic applications. AMIC's focus is o...

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“LMI”), which is a global leader in developing, manufacturing, selling and distributing ...

Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. (www.isotope.com) is the world's premier supplier of stable isotopes and stable isotope labeled compounds for research applications in structu...

Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical ...

Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical...

Neoprobe Corporation and Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agent...

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agent...

KineMed, Inc.

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarkerâ...

Symbiotic Research Services

SR is a contract research organization (CRO) which is licensed to conduct research with radio labeled C-14 materials. SR has been inspected by the US-EPA and the NJ-DEP Division o...

Clinical Trials [338 Associated Clinical Trials listed on BioPortfolio]

Exercise Physiology Study

People with type 1 diabetes often find exercise very difficult to manage, because of the high risk for low blood glucose levels. This can occur very quickly once exercise starts and presen...

Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device

The researchers recognized the possible clinical usefulness of a shielded device or jig to help increase the accuracy but decrease the time of loading the seeds into the biocompatible mate...

Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

The overall goal of this protocol is to evaluate [18F]MNI-968 (aka PF-06730110) as a D1 receptor targeted radiopharmaceutical.

Phase 1 Test-retest Evaluation of [18F]MK-6240 PET as an Imaging Marker for Neurofibrillary Tangles in the Brain

The overall goal of this protocol is to evaluate [18F]MK-6240 (also known as [18F]MNI-946) a tau targeted radiopharmaceutical.

Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy

Introduction: Graves disease (GD) is characterized by thyrotoxicosis and goiter, arising through circulating autoantibodies that bind to and stimulate the thyroid hormone receptor (TSHR). ...

Gastric Cancer Sentinel Lymph Node Mapping

Gastric cancer has an incidence in North America of over 24,000 new cases annually, of which approximately 15% are diagnosed at an early stage. Standard of care for early gastric cancer (E...

Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists

Background: Brown adipose tissue (BAT) is a type of fat in the body. It may prevent weight gain, improve insulin sensitivity, and reduce fatty liver. Researchers want to see if BAT helps ...

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) is a great challenge in the treatment of thyroid cancer. Tyrosine kinase inhibitors (TKIs), like sorafenib and lenvat...

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

This study is designed to identify the best tolerated doses of [131]Iodine-MIBG and [90]Yttrium-DOTATOC when co-administered to treat midgut neuroendocrine tumors. These drugs (131I-MIBG, ...

Mapping Sound Propagation Through the Human Lung for Better Diagnosis

This study addresses the question, how does sound propagate from a source in the chest to the chest wall? Using sound recorded at the chest as a diagnostic technique has the advantage of b...

PubMed Articles [228 Associated PubMed Articles listed on BioPortfolio]

Accuracy of (177)Lu activity quantification in SPECT imaging: a phantom study.

The aim of the study is to assess accuracy of activity quantification of (177)Lu studies performed according to recommendations provided by the committee on Medical Internal Radiation Dose (MIRD) pamp...

Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.

Metastatic lymph node ratio (MLNR) is a known significant predictor of disease-free survival in differentiated thyroid cancer. The authors investigated the ability of preoperative fluorine-18 fluorode...

Dog cloning with in vivo matured oocytes obtained using electric chemiluminescence immunoassay-predicted ovulation method.

Radioactive immunoassay (RIA) is a traditional serum hormone assay method, but the application of the method in reproductive studies is limited by the associated radioactivity. The aim of present stud...

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.

Patients with advanced radioactive iodine resistant differentiated (MDTC) or medullary (MMTC) thyroid cancer had an unmet need. Early data showed promising efficacy of vascular endothelial growth fact...

Technetium-99m-Labeled Sulfadiazine: a Targeting Radiopharmaceutical for Scintigraphic Imaging of Infectious Foci Due To Escherichia coli in Mouse and Rabbit Models.

Bacterial infection is one of the vital reasons of morbidity and mortality, especially in developing countries. It appears silently without bothering the geological borders and imposes a grave threat ...

High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats.

Thyroid concentrates radioactive iodine by sodium-iodide symporter; this is used for treating hyperthyroidism and thyroid cancer. Pancreas expresses NIS and radioactive iodine uptake may damage pancre...

Radioactive contamination of the soil-plant cover at certain locations of Primorsky Krai, Sakhalin Island and Kamchatka Peninsula: Assessment of the Fukushima fallout.

The contamination densities of soil-plant cover at certain locations within the Primorsky Krai, Sakhalin Island and Kamchatka Peninsula attributable to (90)Sr, (137)Cs and (239,240)Pu were 500-1390 Bq...

A retrospective study of ultrasound and FNA cytology investigation of thyroid nodules: working towards combined risk stratification.

The British Thyroid Association recommended in new guidelines on thyroid cancer treatment [Kwak et al. (Korean J Radiol 14:110-117, 2013)] that ultrasound grading of thyroid nodules should be incorpor...

Perceived risks of produced water management and naturally occurring radioactive material content in North Dakota.

Unconventional oil and gas development using hydraulic fracturing has caused conflict and controversy across the globe including the U.S. where some States banned the practice. Nevertheless, North Dak...

Feasibility of magnetic marker localisation for non-palpable breast cancer.

Accurate tumour localisation is essential for breast-conserving surgery of non-palpable tumours. Current localisation technologies are associated with disadvantages such as logistical challenges and m...

Videos

None available.

Medical and Biotech [MESH] Definitions

Radioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like.

Uncontrolled release of radioactive material from its containment. This either threatens to, or does, cause exposure to a radioactive hazard. Such an incident may occur accidentally or deliberately.

Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.

A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

review and buy Nuclear Medicine market research data and corporate reports here

Channels Quicklinks